Back to Trials
NCT04988009Recruiting

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

M.D. Anderson Cancer Center

Start Date

8/20/2020

Completion Date

12/31/2026

Summary

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Detailed Description

PRIMARY OBJECTIVE: I. To evaluate the patient-perceived quality of care by group (telemedicine versus in-person visits) in patients with central nervous system (CNS) cancer. SECONDARY OBJECTIVES: I. To characterize the visits provided by telemedicine compared to those in-person. II. To contrast the average time spent on telemedicine visits compared to in-person visits, and the delay between visit order placement and visit occurring. III. To evaluate the domains of patient care addressed on a telemedicine visit versus in-person visit per documentation, including (1) treatment planning, (2) symptom burden, (3) goals of care. IV. To evaluate frequency of acute care sought (through emergency room or urgent care clinic) within 30 days of encounter in telemedicine visit versus (vs) in-person visit. V. The impact of patient and clinical characteristics on perceived quality of care in the context of covariate-adjusted modeling. OUTLINE: Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be * An in-person visit * A telemedicine appointment Exclusion Criteria: * Encounter occurred with the assistance of official language translation support * Patients with telephone encounters (without interactive video) * New patient or consult visits * Neither patient nor caregiver present during the visit are available or able to answer survey questions

Interventions

OTHER

Electronic Health Record Review

OTHER

Survey Administration

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Central Nervous System NeoplasmLeptomeningeal NeoplasmMetastatic Malignant Neoplasm in the BrainPrimary Brain Neoplasm

Locations

M D Anderson Cancer Center

Houston, Texas 77030

United States